Simon Huck, CEO and founder of emergency prep kit company Judy, discusses how ill-equipped most people are for a disaster.

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!


2 min read

Opinions expressed by Entrepreneur contributors are their own.


Simon Huck is the CEO and founder of Judy, which sells emergency kits, and the principal owner of the company Command Entertainment Group. Huck talks with #ThePlaybook host David Meltzer about emergency preparedness, including the negative perceptions of emergencies and how planning is more critical than supplies. 

Huck discusses his professional background in public relations and entertainment and how it led him to seek mission-focused work. He talks about Judy’s origins as an evolution of his attempt to develop better shelf-stable foods and his discovery of a market for emergency preparedness kits for families. 

Huck says 60 percent of American families don’t have supplies for an emergency. He says that Judy’s mission is to make emergency preparedness part of households with the kits serving as a starting point for conversations about emergency planning. 

Huck talks about the company’s optimistic messaging, the challenges of debunking misconceptions about emergency

A potential coronavirus vaccine developed by Oxford University in the U.K. with pharmaceutical giant AstraZeneca has produced a strong immune response in a large, early-stage human trial, according to newly released data published Monday in the medical journal The Lancet.

The researchers are calling their experimental vaccine ChAdOx1 nCoV-19. It combines genetic material from the coronavirus with a modified adenovirus that is known to cause infections in chimpanzees. The phase one trial had more than 1,000 participants.

AstraZeneca’s shares fell by about 3% in morning trading. 

The researchers said the vaccine produced both antibodies and killer T-cells to combat the infection. Neutralizing antibodies, which scientists believe is important to gain protection against the virus, were detected in participants after 28 days. 

The vaccine was found to be well-tolerated and there were no serious adverse events, according to the researchers. Fatigue and headache were the most commonly reported, they said. Other common side effects included pain at the injection site, muscle ache, chills and a fever.

Professor Adrian Hill, director of Oxford University’s Jenner Institute, told CNBC on Monday that the strong immune response means the vaccine is more likely to provide protection against the virus, though nothing is guaranteed. He

This is the web version of CEO Daily. To get it delivered to your inbox, sign up here.

Good morning.

There’s a new book out this week on the collapse of General Electric by two Wall Street Journal reporters, Thomas Gryta and Ted Mann. (Their Amazon page says the book is already the “#1 Best Seller in Industrial Manufacturing” –which made me wonder what #2 is!) The Journal included an excerpt from the story here this weekend, that focused on the company’s ill-fated effort to champion the “industrial internet” through GE Digital and its Predix software.

I interviewed then-CEO Jeff Immelt about the effort back in 2016, and found, as always, his articulation of the strategy to be compelling. He had lived through the disruption of the media business–GE then owned NBC Universal–by Facebook, Google, Apple, Amazon, and he didn’t want the same thing to happen to his industrial businesses. “If you think about it, 15%, almost 20%, of the S&P 500 are consumer Internet companies, and the existing consumer companies in those areas–media, retail, consumer banking–got none of that,” he said. “I was able to see that. And I passionately believe that if …